Skip to content

Drug interactions

Gilteritinib + Ritonavir

Severity: Major

Gilteritinib and Ritonavir: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ritonavir strongly inhibits CYP3A and P-glycoprotein and can raise gilteritinib exposure. Higher levels may increase toxicities such as QT prolongation, differentiation syndrome, hepatotoxicity and myelosuppression.

What this interaction means in plain words

Gilteritinib and Ritonavir can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Gilteritinib belongs to Oncology; Ritonavir belongs to Anti Virals.

Evidence level: Moderate

Why it happens

Inhibition of CYP3A4 and P-gp by ritonavir reduces gilteritinib clearance and increases its absorption.

What to do

Prefer an alternative antiretroviral or booster-free regimen where possible. If combined, monitor ECG, electrolytes, liver tests and signs of toxicity closely, and consider gilteritinib dose reduction.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Gilteritinib and Ritonavir, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Gilteritinib with Ritonavir?

MediHelp rates the interaction as major. Gilteritinib and Ritonavir can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Ritonavir strongly inhibits CYP3A and P-glycoprotein and can raise gilteritinib exposure. Higher levels may increase toxicities such as QT prolongation, differentiation syndrome, hepatotoxicity and myelosuppression.

How serious is the interaction between Gilteritinib and Ritonavir?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Prefer an alternative antiretroviral or booster-free regimen where possible. If combined, monitor ECG, electrolytes, liver tests and signs of toxicity closely, and consider gilteritinib dose reduction.

What other medicines interact with Gilteritinib?

MediHelp also lists interactions of Gilteritinib with, for example, Pimozide, Amiodarone, Amisulpride. The full list is on the Gilteritinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in